{"schema_version":"secwatch.filing_event.v1","accession":"0001737287-23-000028","form_type":"8-K","ticker":"ALLO","cik":"0001737287","company_name":"Allogene Therapeutics, Inc.","filed_at":"2023-04-20T23:59:59+00:00","discovered_at":"2026-05-14T18:03:40.301046+00:00","generated_at":"2026-06-16T22:38:15.001752+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Allogene CTO Alison Moore resigns; Tim Moore appointed as replacement","bullets":["Alison Moore resigns as Chief Technical Officer effective April 28, 2023 to pursue other opportunities.","Board appoints Tim Moore as CTO effective April 24, 2023; he will also provide transitional consulting.","No further details on reasons for departure or consulting terms were disclosed."],"urls":{"canonical":"https://secwatch.observer/filing/0001737287-23-000028","json":"https://secwatch.observer/filing/0001737287-23-000028.json","markdown":"https://secwatch.observer/filing/0001737287-23-000028.md","text":"https://secwatch.observer/filing/0001737287-23-000028.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1737287/000173728723000028/0001737287-23-000028-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1737287/000173728723000028/allo-20230418.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-16T22:38:15.001752+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"a36d32bef0","claim":"Tim Moore was appointed as Chief Technical Officer at Allogene Therapeutics, Inc..","evidence_excerpt":"On April 19, 2023, the Company’s Board of Directors appointed Tim Moore to serve as Chief Technical Officer, effective April 24, 2023.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1737287/000173728723000028/0001737287-23-000028-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Technical Officer"}],"fact_type":"executive_change"},{"claim_id":"e48c76fea2","claim":"Alison Moore resigned as Chief Technical Officer at Allogene Therapeutics, Inc..","evidence_excerpt":"On April 18, 2023, Alison Moore, the Chief Technical Officer of Allogene Therapeutics, Inc. (the “Company”), notified the Company of her decision to resign effective April 28, 2023 to pursue other opportunities.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1737287/000173728723000028/0001737287-23-000028-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Chief Technical Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}